Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Transcriptome sequencing of hepatocellular carcinoma cells exposed to nanoparticles

PROVIDER: PRJNA930960 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR23351483_1.fastq.gz	Fastqsanger.gz
	SRR23351483_2.fastq.gz	Fastqsanger.gz
	SRR23351484_1.fastq.gz	Fastqsanger.gz
	SRR23351484_2.fastq.gz	Fastqsanger.gz
	SRR23351485_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 24

Similar Datasets

Differential Genomic Effects of Six Different Nanomaterials on Human Liver HepG2 Cells

Project description:Human Hepatocellular Carcinoma cells (HepG2) were exposed to six nanomaterials containing either Cerium oxide (CeO2) or Titanium oxide (TiO2) nanoparticles. Three different concentrations were tested: 0.3, 3, or 30 μg/mL) for 3 days. Microarray analysis was performed to identify genes differentially expressed following exposure to these chemicals.

2018-08-28 | GSE117056 | GEO

Human hepatocellular carcinoma Orbitrap-LC-MS-HZ

Project description:Human hepatocellular carcinoma cells were subcutaneously implanted into nude mice and treated with photodynamic nanoparticles (NP3) with laser, followed by tissue collection and proteomic analysis.

2023-10-24 | PXD041112 | Pride

Extracellular vesicle based therapeutic targeting of b-catenin to modulate anti-cancer immune responses in Hepatocellular Cancer

Project description:Combination therapy with anti PD-1 and β -catenin siRNA delivered using biological nanoparticles provide an effective strategy for the treatment of Hepatocellular carcinoma.

2018-10-02 | GSE120714 | GEO

SM5-1-conjugated gold nanoparticles for antibody therapy in hepatocellular carcinoma

Project description:As a humanized mouse antibody, SM5-1 can target a membrane protein of about 230kDa over-expressed in hepatocellular carcinoma (HCC), melanoma and breast cancer and it has been found to inhibit the progress of tumor cells. In this study, SM5-1 conjugated gold nanoparticles were prepared to study the antitumor efficacy in the treatment of HCC-LM3-fLuc tumor. The results showed that AU-SM5-1 could inhibit HCC-LM3 hepatocellular carcinoma cell proliferation up to 71.26% at the concentration of 0.5mg/ml contrast with SM5-1 and gold nanoparticles. In order to address the mechanism of the antiproliferative effects of AU-SM5-1, we examined the gene expression in HCC-LM3-fLuc tumor cells based on gene-chip screening. The gene chip results showed that some cycle-related and reactive oxygen species (ROS) related genes including up-regulated P21 and down-regulated duox2 and nox1 genes which were validated by real-time quantitative polymerase chain reaction (PCR).

2014-07-11 | E-GEOD-59284 | biostudies-arrayexpress

SM5-1-conjugated gold nanoparticles for antibody therapy in hepatocellular carcinoma

2014-07-11 | GSE59284 | GEO

E-GEOD-33294

Project description:Transcriptome sequencing of human hepatocellular carcinoma

2025-01-24 | E-GEOD-33294 | ExpressionAtlas

Transcriptome study of Caco-2 human intestinal cells following exposure to empty or S-nitrosoglutathione-loaded polymeric nanoparticles

Project description:To further study the transcriptome of Caco-2 human colon epithelial-like cells after exposure to S-nitrosoglutathione (GSNO, 1.4 Î¼M), or Eudragit RL PO polymeric nanoparticles (NP-ERL, 50 Î¼g/mL) or GSNO loaded nanoparticles (NP-GSNO, 50 Î¼g/mL corresponding to (1.4 Î¼M GSNO) we investigate whole genome microarray to identify genes regulates by exposure or not to GSNO (1.4 Î¼M) or Eudragit RL PO polymeric nanoparticles (NP-ERL, 50 Î¼g/mL) or GSNO loaded nanoparticles (NP-GSNO, 50 Î¼g/mL corresponding to (1.4 Î¼M GSNO). Changes in gene expression in Caco-2 cells incubated without (control) or with GSNO or nanoparticles for 4 h, were measured. Four biological replicates were performed as controls: S46_1_4 ; S46_1_3 ; S35_1_4 ; S35_1_3. Four biological replicates were performed for each conditions : wtih GSNO (1.4 ÂµM) exposed cells (S46_2_2 ; S46_2_1 ; S35_2_2 ; S35_2_1), with NP-ERL (50 Î¼g/mL) exposed cells (S46_1_2 ; S46_1_1 ; S35_1_2 ; S35_1_1) with NP-GSNO (50 Î¼g/mL corresponding to 1.4 ÂµM GSNO) exposed cells (S46_2_4 ; S46_2_3 ; S35_2_4 ; S35_2_3)

2015-12-31 | E-GEOD-69551 | biostudies-arrayexpress

Project description:Transcriptome analysis of hepatocellular carcinoma cells

| PRJNA643657 | ENA

Single-cell and Spatial Architecture of Primary Liver Cancer

Project description:Using single-cell RNA sequencing, spatial transcriptomic and bulk multi-omics, we elaborated a molecular architecture of 3 PLC types, namely hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC) and combined hepatocellular-cholangiocarcinoma (CHC) from a high-resolution perspective.

2024-01-26 | PXD044778 | Pride

Using RNA sequencing to identify key microRNAs and hub genes in the progression of hepatocellular carcinoma

Project description:This project completed the transcriptome analysis of 6 samples and obtained 12142010 reads Clean Data (after quality control sequencing data). The average clean data volume of each sample was 1833443535 bp , the Q30 base percentage was over 80%, and the GC content was 68.15. % To 46.53%. In this study, we used RNA sequencing and integrated bioinformatics approach to explore hub miRNA-mRNA interactions that are highly associated with hepatocellular carcinoma development. Our data indicated that miR-139-5p is closely related to the overall survival rate of hepatocellular carcinoma patients and directly combines with ITGB8 to regulate its expression.

2021-10-17 | GSE185913 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data